BSV-003
Cytomegalovirus (CMV)
PreclinicalActive
Key Facts
About Kimer Med
Kimer Med builds modular, host‑targeted biologics to deliver broad‑spectrum antivirals for pandemic‑ready therapeutics.
View full company profileTherapeutic Areas
Other Cytomegalovirus (CMV) Drugs
| Drug | Company | Phase |
|---|---|---|
| VBI-1501 | VBI Vaccines | Phase 1 |